Unknown

Dataset Information

0

Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.


ABSTRACT: A novel single-walled carbon nanotube (SWNT)-based tumor-targeted drug delivery system (DDS) has been developed, which consists of a functionalized SWNT linked to tumor-targeting modules as well as prodrug modules. There are three key features of this nanoscale DDS: (a) use of functionalized SWNTs as a biocompatible platform for the delivery of therapeutic drugs or diagnostics, (b) conjugation of prodrug modules of an anticancer agent (taxoid with a cleavable linker) that is activated to its cytotoxic form inside the tumor cells upon internalization and in situ drug release, and (c) attachment of tumor-recognition modules (biotin and a spacer) to the nanotube surface. To prove the efficacy of this DDS, three fluorescent and fluorogenic molecular probes were designed, synthesized, characterized, and subjected to the analysis of the receptor-mediated endocytosis and drug release inside the cancer cells (L1210FR leukemia cell line) by means of confocal fluorescence microscopy. The specificity and cytotoxicity of the conjugate have also been assessed and compared with L1210 and human noncancerous cell lines. Then, it has unambiguously been proven that this tumor-targeting DDS works exactly as designed and shows high potency toward specific cancer cell lines, thereby forming a solid foundation for further development.

SUBMITTER: Chen J 

PROVIDER: S-EPMC2888730 | biostudies-literature | 2008 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Functionalized single-walled carbon nanotubes as rationally designed vehicles for tumor-targeted drug delivery.

Chen Jingyi J   Chen Shuyi S   Zhao Xianrui X   Kuznetsova Larisa V LV   Wong Stanislaus S SS   Ojima Iwao I  

Journal of the American Chemical Society 20081201 49


A novel single-walled carbon nanotube (SWNT)-based tumor-targeted drug delivery system (DDS) has been developed, which consists of a functionalized SWNT linked to tumor-targeting modules as well as prodrug modules. There are three key features of this nanoscale DDS: (a) use of functionalized SWNTs as a biocompatible platform for the delivery of therapeutic drugs or diagnostics, (b) conjugation of prodrug modules of an anticancer agent (taxoid with a cleavable linker) that is activated to its cyt  ...[more]

Similar Datasets

| S-EPMC2886730 | biostudies-literature
| S-EPMC9703093 | biostudies-literature
| S-EPMC3292351 | biostudies-literature
| S-EPMC8066293 | biostudies-literature
| S-EPMC2505197 | biostudies-literature
| S-EPMC8709863 | biostudies-literature
| S-EPMC3905603 | biostudies-literature
| S-EPMC3675050 | biostudies-literature
| S-EPMC2639792 | biostudies-literature
| S-EPMC7237200 | biostudies-literature